Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $1.46, $0.12 better than the analyst estimate of $1.34. Revenue for the quarter came in at $351.2 million versus the consensus estimate of $347.24 million.

GUIDANCE:

Medpace Holdings sees FY2022 EPS of $6.07-$6.36, versus the consensus of $5.82. Medpace Holdings sees FY2022 revenue of $1.405-1.435 million, versus the consensus of $1.4 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.